Relaxo Footwear's financial history is a record of steady, if occasionally volatile, volume-led revenue growth punctuated by earnings pressure when raw material costs spike — a pattern characteristic of mass-market manufacturing businesses dependent on petrochemical-derived inputs. In FY2018, Relaxo reported revenues of approximately 21.6 billion rupees, with a net profit of approximately 1.4 billion rupees and a net margin of approximately 6.5 percent. These metrics reflected a business in steady growth mode: volume expansion driving revenue, manufacturing scale driving cost efficiency, and the Sparx brand premiumization gradually improving the revenue-per-pair metric. FY2020 and FY2021 were disrupted by the COVID-19 pandemic. Manufacturing shutdowns, supply chain disruptions, and the collapse of retail footfall — particularly in the April to June 2020 quarter — caused Relaxo's revenues to decline sharply in FY2021 before recovering strongly in FY2022 as economic activity normalized. The pandemic quarter exposed the business's vulnerability to demand-side shocks but also validated the resilience of its mass-market positioning: basic footwear is among the first consumer expenditure categories to recover as household finances stabilize. FY2022 was a breakout year for revenue, with Relaxo reporting approximately 30 billion rupees — the highest in company history — driven by post-COVID demand recovery, volume growth, and some benefit from Sparx's premiumization lifting average selling prices. Net profit in FY2022 was approximately 1.9 billion rupees. FY2023 was a more difficult year. Sharp increases in EVA and rubber prices — driven by global supply chain disruptions and elevated crude oil prices — compressed Relaxo's gross margins significantly. Revenue remained broadly flat at approximately 29 billion rupees, but net profit declined to approximately 1.1 billion rupees as raw material cost inflation outpaced the company's ability to raise prices without losing volume in price-sensitive segments. This earnings compression was consistent across the Indian footwear industry and was not specific to Relaxo's operations. FY2024 showed partial recovery as raw material prices moderated, with revenues of approximately 27 to 29 billion rupees and net profit recovery toward 1.3 to 1.5 billion rupees. The company's balance sheet remains conservative — Relaxo carries minimal long-term debt, preferring to fund capital expenditure from operating cash flows. Net debt is near zero, reflecting the capital efficiency of the business model and the family's preference for financial conservatism. Relaxo's market capitalisation has been one of the more interesting aspects of its financial story. Despite being a mass-market manufacturer with relatively thin margins, Relaxo has commanded premium equity valuations — price-to-earnings multiples of 50 to 80 times in peak market cycles — reflecting investor enthusiasm for branded consumer goods companies serving India's large aspirational consumer base. These valuations have compressed somewhat as earnings growth disappointed in FY2023, but the long-term equity re-rating of Indian branded consumer companies remains a structural tailwind for Relaxo's investor returns.